NASDAQ: LYCA
Lycia Therapeutics Inc Earnings Dates, Reports, Calls

Lycia Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LYCA earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LYCA reported annual earnings of -$36.5M, with 37.6% growth.

LYCA earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

LYCA Return on Equity

Insufficient data to display

LYCA Return on Assets

Insufficient data to display

Be the first to know when LYCA announces earnings.

LYCA Return on Capital Employed

Current Company
0%
Current Industry
-7.4%

LYCA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.51M-$69.89MN/A-$3.21
ACET-$89.96M-$98.97MN/A-$10.46
ABVC-$6.46M-$7.11MN/A-$0.29
ABVX-$285.22M-$460.11MN/A-$5.96
TRXBN/AN/AN/AN/A

Lycia Therapeutics Earnings Reports & History FAQ

What was LYCA's earnings growth in the past year?

As of Lycia Therapeutics's earnings date in Q4 2026, Lycia Therapeutics's earnings has grown year over year. LYCA earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy Lycia Therapeutics stock.

Is Lycia Therapeutics profitable or losing money?

As of the last Lycia Therapeutics earnings report, Lycia Therapeutics is currently losing money. Lycia Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.